Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1

Genes and Development

Volumn 12, Issue 22, 1998, Pages 3488-3498

  Zwijsen, Renate M L ^a   Buckle, Robin S ^b   Hijmans, E Marielle ^a   Loomans, Cindy J M ^a   Bernards, René ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b Prolifix Ltd   (United Kingdom)

Author keywords

Breast cancer; Coactivator; Cyclin D1; Estrogen receptor; SRC 1

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR; STEROID RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CELL DIFFERENTIATION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0032533881     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.22.3488     Document Type: Article

References (53)

1. Andersen, G., D. Busso, A. Poterszman, J.R. Hwang, J.M. Wurtz, R. Ripp, J.C. Thierry, J.M. Egly, and D. Moras. 1997. The structure of cyclin H: Common mode of kinase activation and specific features. EMBO J. 16: 958-967.
2. Anzick, S.L., J. Konomen, R.L. Walker, D.O. Azorsa, M.M. Tanner, X.Y. Guan, G. Sauter, O.P. Kallioniemi, J.M. Trent, and P.S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968.
3. Baniahmad, A., I. Ha, D. Reinberg, S. Tsai, M.J. Tsai, and B.W. O'Malley. 1993. Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl. Acad. Sci. 90: 8832-8836.
4. Beato, M. 1989. Gene regulation by steroid hormones. Cell 56: 335-344.
5. Beijersbergen, R.L. and R. Bernards. 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochem. Biophys. Acta Rev. Cancer 1287: 103-120.
6. Brzozowski, A.M., A.C.W. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G.L. Greene, J.-A. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758.
7. Buckley, M.F., K.J. Sweeney, J.A. Hamilton, R.L. Sini, D.L. Manning, R.I. Nicholson, A. deFazio, C.K. Watts, E.A. Musgrove, and R.L. Sutherland. 1993. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133.
8. Cavailles, V., S. Dauvois, P.S. Danielian, and M.G. Parker. 1994. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. 91: 10009-10013.
9. Chakravarti, D., V.J. LaMorte, M.C. Nelson, T. Nakajima, I.G. Schulman, H. Juguilon, M. Montminy, and R.M. Evans. 1996. Role of CBP/P300 in nuclear receptor signalling. Nature 383: 99-103.
10. Chen, H., R.J. Lin, R.L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M.L. Privalsky, Y. Nakatani, and R.M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90: 569-580.
11. Danielian, P.S., R. White, J.A. Lees, and M.G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11: 1025-1033.
12. Evans, R.M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
13. Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes & Dev. 9: 2364-2372.
14. Gillett, C., V. Fantl, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes, and G. Peters. 1994. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54: 1812-1817.
15. Gillett, C., P. Smith, W. Gregory, M. Richards, R. Millis, and G. Peters. 1996. Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer 69: 92-99.
16. Hanstein, B., R. Eckner, J. DiRenzo, S. Halachmi, H. Liu, B. Searcy, R. Kurokawa, and M. Brown. 1996. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. 93: 11540-11545.
17. Heery, D.M., E. Kalkhoven, S. Hoare, and M.G. Parker. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387: 733-736.
18. Hong, H., K. Kohli, M.J. Garabedian, and M.R. Stallcup. 1997. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell. Biol. 17: 2735-2744.
19. Ing, N.H., J.M. Beekman, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1992. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267: 17617-17623.
20. Jacq, X., C. Brou, Y. Lutz, I. Davidson, P. Chambon, and L. Tora. 1994. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79: 107-117.
21. Jeffrey, P.D., A.A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massagué, and N. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376: 313-320.
22. Jenster, G., T.E. Spencer, M.M. Burcin, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1997. Steroid receptor induction of gene transcription: a two-step model. Proc. Natl. Acad. Sci. 94: 7879-7884.
23. Kalkhoven, E., J.E. Valentine, D.M. Heery, and M.G. Paerker. 1998. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 17: 232-243.
24. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Glass, S.-C. Lin, R.A. Heyman, D.W. Rose, C.K. Glass, and M.G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
25. Kumar, V. and P. Chambon. 1988. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145-156.
26. Kumar, V., S. Green, G. Stack, M. Berry, J.R. Jin, and P. Chambon. 1987. Functional domains of the human estrogen receptor. Cell 51: 941-951.
27. Le Douarin, B., C. Zechel, J.-M. Gamier, Y. Lutz, L. Tora, B. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14: 2020-2033.
28. Le Douarin, B., A.L. Nielsen, J.M. Garnier, H. Ichinose, F. Jeanmougin, R. Losson, and P. Chambon. 1996. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 15: 6701-6715.
29. Li, H., P.J. Gomes, and J.D. Chen. 1997. RAC3, a steroid/ nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. 94: 8479-8484.
30. Mitchell, P.J. and R. Tjian. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245: 371-388.
31. Musgrove, E.A., C.S. Lee, M.F. Buckley, and R.L. Sutherland. 1994. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. 91: 8022-8026.
32. Neuman, E., M.H. Ladha, N. Lin, T.M. Upton, S.J. Miller, J. DiRenzo, R.G. Pestell, P.W. Hinds, S.F. Dowdy, M. Brown, and M.E. Ewen. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17: 5338-5347.
33. Ogryzko, V.V., R.L. Schiltz, V. Russanova, B.H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
34. Onate, S.A., S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
35. Pugh, B.F. and R. Tjian. 1990. Mechanism of transcriptional activation by Sp1: Evidence for coactivators. Cell 61: 1187-1197.
36. Renaud, J.P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378: 681-689.
37. Rost, B. and C. Sander. 1993. Prediction of protein secondary structure at better than 70% accuracy. J. Mol. Biol. 232: 584-599.
38. Sadovsky, Y., P. Webb, G. Lopez, J.D. Baxter, P.M. Fitzpatrick, G.E. Gizang, V. Cavailles, M.G. Parker, and P.J. Kushner. 1995. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell. Biol. 15: 1554-1563.
39. Schuuring, E., E. Verhoeven, W.J. Mooi, and R.J. Michalides. 1992a. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7: 355-361.
40. Schuuring, E., E. Verhoeven, H. van Tinteren, J.L. Peterse, B. Nunnink, F.B. Thunnissen, P. Devilee, C.J. Cornelisse, M. van de Vijver, W.J. Mooi et al. 1992b. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 52: 5229-5234.
41. Sicinski, P., J.L. Donaher, S.B. Parker, T. Li, A. Fazeli, H. Gardner, S.Z. Haslam, R.T. Bronson, S.J. Elledge, and R.A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630.
42. Smith, C.L., S.A. Onate, M.J. Tsai, and B.W. O'Malley. 1996. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. 93: 8884-8888.
43. Spencer, T.E., G. Jenster, M.M. Burcin, C.D. Allis, J. Zhou, C.A. Mizzen, N.J. McKenna, S.A. Onate, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389: 194-198.
44. Torchia, J., D.W. Rose, J. Inostroza, Y. Kamei, S. Westin, C.K. Glass, and M.G. Rosenfeld. 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387: 677-684.
45. Tzukerman, M.T., A. Esty, M.D. Santiso, P. Danielian, M.G. Parker, R.B. Stein, J.W. Pike, and D.P. McDonnell. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol. 8: 21-30.
46. van Diest, P.J., R.J. Michalides, L. Jannink, P. van der Valk, H.L. Peterse, J. de Jong, C.J. Meijer, and J.P. Baak. 1997. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am. J. Pathol. 150: 705-711.
47. Voegel, J.J., M.J.S. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation of AF-2 of nuclear receptors. EMBO J. 15: 3667-3675.
48. vom Baur, E., C. Zechel, D. Heery, M.J. Heine, J.M. Gamier, V. Vivat, D.B. Le, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15: 110-124.
49. Wang, T.C., R.D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E.V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671.
50. White, R., M. Sjoberg, E. Kalkhoven, and M.G. Parker. 1997. Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 16: 1427-1435.
51. Yao, T.P., G. Ku, N. Zhou, R. Scully, and D.M. Livingston. 1996. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. 93: 10626-10631.
52. Zwijsen, R.M., R. Klompmaker, E.B. Wientjens, P.M. Kristel, B. van der Burg, and R.J. Michalides. 1996. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol. 16: 2554-2560.
53. Zwijsen, R.M.L., E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards, and R.J.A.M. Michalides. 1997. CDK-independent activation of estrogen receptor by cyclin D1. Cell 88: 405-415.